Vaccination with recombinant viral vectors may be impeded by preexisting vector-specific immunity or by vector-specific immunity induced during the priming immunization. It is assumed that ...
Heterologous prime-boost vaccination induces robust mucosal and systemic immunity against SARS-CoV-2
They have shown that intranasal administration of adenovirus vector-based booster vaccine following prime immunization with a DNA- or mRNA-based vaccine induces robust mucosal and systemic antibody ...
A Massachusetts woman takes part in a clinical trial for a COVID-19 vaccine. Craig F. Walker/The Boston Globe via Getty Images Sign up for our special edition newsletter to get a daily update on the ...
Pseudomonas aeruginosa is a bacterium that can cause respiratory tract infections, which can be life threatening in patients who have cystic fibrosis. It is therefore important to develop a vaccine ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback